Investor insights
Countries invested in
Sectors invested in
Funding rounds participated in
$45M sweet spot round size
Most of their 68 investments are in rounds between $18M and $103M
Investor type
Basic info
Industry
Sectors
Date founded
2012
Investments made
Cellares raised $255M on August 23, 2023
Investors: DFJ Growth, Koch Disruptive Technologies, Willett Advisors LLC, Bristol-Myers Squibb, UK, 8VC, Eclipse Ventures and Decheng Capital
CG Oncology raised $105M on August 2, 2023
Investors: Avidity Partners, TCG X, Foresite Capital, RA Capital Management, L.P., Malin Corporation plc, Longitude Capital and Decheng Capital
CG Oncology raised $105M on August 2, 2023
Investors: Foresite Capital, Malin Corporation plc, Longitude Capital, TCG X, Avidity Partners, RA Capital Management, L.P. and Decheng Capital
Undisclosed raised $200M on June 8, 2023
Investors: TCG X, Omega Funds, Samsara BioCapital, OrbiMed Advisors, Enavate Sciences, Wellington Management and Decheng Capital
Vinta Bio raised $64M on April 11, 2023
Investors: Decheng Capital
CG Oncology raised $120M on November 15, 2022
Investors: RA Capital Management, L.P., Acorn Bioventures, ORI Capital Limited, Sirona Capital, Longitude Capital and Decheng Capital
LevitasBio raised $35M on October 24, 2022
Investors: Novalis LifeSciences LLC and Decheng Capital
Watchmaker Genomics raised $40M on June 2, 2022
Investors: Eclipse Ventures and Decheng Capital
北京优迅医学检验实验室有限公司 raised undisclosed on May 12, 2022
Investors: 北京中关村海外科技园有限责任公司 and Decheng Capital
Nalu Medical, Inc. raised $104M on February 17, 2022
Investors: Gilde Healthcare, Aperture Venture Partners, Advent Life Sciences, Pura Vida Investments, Longitude Capital, MVM Partners, Endeavour Vision and Decheng Capital